Introduction

Vincristine Related

Cisplatinum Related

Other Rx Related

Therapy

References

 

 

 

Home > Disclaimer > Late Effects

 

Late Effects

Peripheral Nervous System

 

Cisplatinum Related Neuropathy

 

Cisplatinum predominantly a sensory peripheral neuropathy with the dorsal root ganglion being the primary target5.

Neuropathy occurs in as many as 75% of patients.

Carboplatinum can also cause peripheral neuropathy (much less likely to cause this than Cisplatinum)3.

Symptoms:

  • Paresthesias
  • Dysesthesias
  • Position and vibration sense disturbed
  • Motor units are spared

 

Investigation:

  • Sensory nerve conduction studies show:
    • Decrease or absence of sensory nerve action potentials
    • Delayed sensory nerve conduction velocities
  • Motor nerve conduction and EMG are normal

 

Risk factors:

  • Cumulative dose
  • Amofostine has a protective effect on subclinical neurotoxicity when given with cisplatinum.

 

Prognosis:

  • Severe acute neurotoxicity usually resolves
  • 20-60% of patients may be left with persistent paresthesias following therapy

 

 

Back to top

Next